Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short-term Investments (2021 - 2022)

Biodesix (BDSX) has disclosed Short-term Investments for 2 consecutive years, with $100000.0 as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Short-term Investments changed N/A year-over-year to $100000.0, compared with a TTM value of $100000.0 through Jun 2022, changed N/A, and an annual FY2021 reading of $100000.0, changed N/A over the prior year.
  • Short-term Investments was $100000.0 for Q2 2022 at Biodesix, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $100000.0 in Q4 2021 and bottomed at $100000.0 in Q4 2021.